- Home
- MRTN vs XERS Comparison
MRTN vs XERS Comparison
Compare MRTN & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRTN | XERS |
|---|---|---|
| Founded | 1946 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MRTN | XERS |
|---|---|---|
| Price | $13.64 | $6.19 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.83 |
| AVG Volume (30 Days) | 711.6K | ★ 1.6M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.70% | N/A |
| EPS Growth | N/A | ★ 100.00 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $1,131,455,000.00 | $49,590,000.00 |
| Revenue This Year | $2.23 | $34.37 |
| Revenue Next Year | $8.59 | $22.83 |
| P/E Ratio | $67.19 | ★ N/A |
| Revenue Growth | N/A | ★ 142.67 |
| 52 Week Low | $9.35 | $3.95 |
| 52 Week High | $14.35 | $10.08 |
Technical Indicators
Market Signals| Indicator | MRTN | XERS |
|---|---|---|
| Relative Strength Index (RSI) | 55.39 | 56.74 |
| Support Level | $11.43 | $4.87 |
| Resistance Level | $14.07 | $7.21 |
| Average True Range (ATR) | 0.38 | 0.26 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 56.93 | 93.23 |
Price Performance
Historical ComparisonAbout MRTN Marten Transport Ltd.
Marten Transport Ltd is a temperature-sensitive and dry truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. The company operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services transporting food and other consumer packaged goods.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.